Curanex Pharmaceuticals Inc Common Stock

Share · US23126K1060 · CURX (XNAS)

Overview

AI-Powered Analysis

Fundamental Analysis

Find out what the numbers really say — before the market does

Analyze now

News Sentiment

Are today's headlines a buy signal or a red flag?

Analyze now

Buy / Hold / Sell

Should you Buy, Hold, or Sell? Get the AI verdict now.

Analyze now

Risk Assessment

Uncover hidden risks before they hit your portfolio.

Analyze now

Fair Value

Is this stock cheap, fairly priced, or overvalued?

Analyze now

Latest AI Analyses of Curanex Pharmaceuticals Inc Common Stock

No Price

28.04.2026 16:18

Current Prices from Curanex Pharmaceuticals Inc Common Stock

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	CURX	USD	28.04.2026 16:18	0,43 USD	0,003 USD +0,73 %
IEX	CURX	USD	28.04.2026 15:14	0,43 USD	0,005 USD +1,25 %

Share Float & Liquidity

Free Float 26,59 %

Shares Float 7,53 M

Shares Outstanding 28,34 M

Company Profile for Curanex Pharmaceuticals Inc Common Stock Share

Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients suffering from inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, gout, and acne. The company was formerly known as Fordman Pharma Inc. and changed its name to Curanex Pharmaceuticals Inc in November 2023. The company was founded in 1996 and is headquartered in Jericho, New York.